Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by Alba1314on Jul 31, 2018 7:47am
144 Views
Post# 28389714

RE:RE:RE:Position

RE:RE:RE:PositionI agree with most of what regardless is saying with one exception: I dont beleive a pp would be done at $0.10. There is zero incentive for a private placement at market value. If a pp is done at sp, there will be some sort of offering of cheaper shares at a future value, diluting the share base. That, or a straight pp done for less than current the sp, which again, dilute current share value. Either way, I think the sop will drop with a private placement. 

A joint venture, on the other hand, would send the sp upwards due to shared risk and no dilution.

However you look at it, this stock is still worth the risk. It's a 50/50 chance of making money. The trials are going to be positive or negative. if you think positive buy and hold. If not, short the stock near the end of the trial. 

Any other BS about the daily sp going up or down is for day traders.
<< Previous
Bullboard Posts
Next >>